Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Event: ESC Congress 2022
Topic: Antiplatelet Drugs
Session: Short and long-term antiplatelet therapy in clinical practice
